Research laboratory services | Tenderlake

Research laboratory services

Contract Value:
-
Notice Type:
Contract award notice
Published Date:
27 June 2022
Closing Date:
Location(s):
UKH EAST OF ENGLAND (UK UNITED KINGDOM)
Description:
CEFAS22-11 Next Generation Sequencing (NGS Framework)

To help meet increasing needs, Cefas have a requirement to establish a new framework agreement for the provision of Next Generation Sequencing (NGS) services to include the approaches detailed below, and any proposed solution/awarded Provider must be able to fulfil the following requirements (as a minimum):

1. The service provided must include the receipt of sample(s) from Cefas, Library Preparation, Quality Control and sequencing, and delivery of data back to Cefas.

2. The service provided must be able to offer, depending on the requirements of the project, a range of NGS technical options including but not restricted to high throughput short and long read sequencing (including Illumina MiSeq, HiSeq, and NovaSeq platforms, PacBio, and Oxford Nanopore Technologies) for a diverse range of sequencing requirements, including but not restricted to amplicon sequencing (metabarcoding and multiplexed protocols), whole/partial genome sequencing, mitogenomics, genome skimming, metagenomics and metatranscriptomics, RNASeq, and hybrid approaches.

Depending on the requirements of the project, some processing and initial analyses of the raw data may be requested. Collaborative, jointly-authored projects will also be undertaken, with input from both parties.

To help meet increasing needs, Cefas have a requirement to establish a new framework agreement for the provision of Next Generation Sequencing (NGS) services to include the approaches detailed below, and any proposed solution/awarded Provider must be able to fulfil the following requirements (as a minimum):

1. The service provided must include the receipt of sample(s) from Cefas, Library Preparation, Quality Control and sequencing, and delivery of data back to Cefas.

2. The service provided must be able to offer, depending on the requirements of the project, a range of NGS technical options including but not restricted to high throughput short and long read sequencing (including Illumina MiSeq, HiSeq, and NovaSeq platforms, PacBio, and Oxford Nanopore Technologies) for a diverse range of sequencing requirements, including but not restricted to amplicon sequencing (metabarcoding and multiplexed protocols), whole/partial genome sequencing, mitogenomics, genome skimming, metagenomics and metatranscriptomics, RNASeq, and hybrid approaches.

Depending on the requirements of the project, some processing and initial analyses of the raw data may be requested. Collaborative, jointly-authored projects will also be undertaken, with input from both parties.

Awarded to:
CEFAS22-11 Next Generation Sequencing Services Framework
CeGat GmbH, Tübingen (DE)
CeGat GmbH, Tübingen (DE)
CeGat GmbH, Tübingen (DE)
CeGat GmbH, Tübingen (DE)
Macrogen Europe BV, Amsterdam (NL)
Macrogen Europe BV, Amsterdam (NL)
Macrogen Europe BV, Amsterdam (NL)
Macrogen Europe BV, Amsterdam (NL)
Novogene (UK) Company Limited, Cambridge (UK)
Novogene (UK) Company Limited, Cambridge (UK)
Novogene (UK) Company Limited, Cambridge (UK)
Novogene (UK) Company Limited, Cambridge (UK)
The University of Exeter, Exeter, Devon (UK)
The University of Exeter, Exeter, Devon (UK)
The University of Exeter, Exeter, Devon (UK)
The University of Exeter, Exeter, Devon (UK)
Download full details as .pdf
The Buyer:
Cefas
CPV Code(s):
73111000 - Research laboratory services